Zobrazeno 1 - 10
of 1 131
pro vyhledávání: '"Barger, D."'
Autor:
S.C. Tiwari
Publikováno v:
Contemporary Physics. 54:120-121
Autor:
Ben Farhat J; Department of Epidemiology and Training, Epicentre, Médecins Sans Frontières, Paris, France.; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France.; Univ. Bordeaux, INSERM, BPH, U1219, Team PHARes, Bordeaux, France., Tiendrebeogo T; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Malateste K; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Poda A; Department of Infectious Diseases, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso., Minga A; Centre médical de Suivi des Donneurs de Sang (CMSDS), Centre National de Transfusion Sanguine (CNTS), Abidjan, Côte d'Ivoire., Messou E; Centre de Prise en charge de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire.; Programme PACCI/ANRS Research Center, Abidjan, Côte d'Ivoire.; Département de Dermatologie et d'Infectiologie, Unité de Formation et de Recherche des Sciences Médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire., Chenal H; Virology Laboratory, Integrated Centre for Bioclinical Research in Abidjan (CIRBA), BP 2071 Abidjan, Côte d'Ivoire., Ezechi O; Office of the Central Secretariat, Nigeria Institute for Medical Research, Yaba, Lagos, Nigeria., Ofotokun I; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Ekouevi DK; Université de Lomé, Département de Santé Publique, Lomé, Togo ; and., Bonnet F; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France.; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, INSERM, U1219, Bordeaux, France ., Barger D; Univ. Bordeaux, INSERM, BPH, U1219, Team PHARes, Bordeaux, France., Jaquet A; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 Jun 01; Vol. 96 (2), pp. 114-120.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ben Farhat J; Department of Epidemiology and Training, Epicentre, Médecins Sans Frontières, Paris, France.; Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux, France., Hessamfar M; Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux, France.; CHU de Bordeaux, COREVIH Nouvelle Aquitaine, Bordeaux, France.; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France., Farbos S; CH de la Côte Basque, Service de maladies infectieuses, Centre Hospitalier de la Côte Basque, Bayonne, France., Desclaux A; CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, Bordeaux, France., Dumondin G; CH de François Mitterrand de Pau, Pau, France., Ferrand H; CH de Libourne Robert Boulin, Libourne, France., Greib C; CHU de Bordeaux, Service de Médecine Interne, Pessac, France., Castan B; CH de Périgueux, Service de Médecine Polyvalente, Périgueux, France., Rispal P; Centre Hospitalier Agen-Nérac, Agen, France., Duffau P; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; Department of Immunology, UMR 5164, ImmunoConcEpT, CNRS, Bordeaux, France., Leleux O; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, France., Perrier A; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, France., Wittkop L; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, France.; INRIA SISTM team, Talence, France; and.; CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, France., Bonnet F; Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux, France.; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, France., Barger D; Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux, France.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 Jan 01; Vol. 95 (1), pp. 1-5.
Autor:
Barger D; Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France. diana.barger@u-bordeaux.fr., Hessamfar M; Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 33000, Bordeaux, France.; CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 33000, Bordeaux, France., Neau D; CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, 33000, Bordeaux, France., Farbos S; CH de la Côte Basque, Service de Maladies Infectieuses, 64000, Bayonne, France., Leleux O; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, 33000, Bordeaux, France., Cazanave C; CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, 33000, Bordeaux, France., Rouanes N; CH de Périgueux, Service de Médecine Polyvalente, 24019, Périgueux, France., Duffau P; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 33000, Bordeaux, France.; Univ. Bordeaux, Department of Immunology, CNRS, ImmunoConcEpT, UMR 5164, 33000, Bordeaux, France., Lazaro E; CHU de Bordeaux, Service de Médecine Interne, 33604, Pessac, France., Rispal P; CH de Agen-Nerac, Service de Médecine Interne, 47923, Agen, France., Dabis F; Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.; CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 33000, Bordeaux, France., Wittkop L; Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, 33000, Bordeaux, France.; INRIA, SISTEM Team, 33400, Talence, France.; CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, 33000, Bordeaux, France., Bonnet F; Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 33000, Bordeaux, France.; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, 33000, Bordeaux, France.
Publikováno v:
Scientific reports [Sci Rep] 2023 Oct 02; Vol. 13 (1), pp. 16535. Date of Electronic Publication: 2023 Oct 02.
Autor:
Atkinson, Andrew, Zwahlen, Marcel, Barger, D, D'Arminio Monforte, A, De Wit, S, Ghosn, J, Girardi, E, Svedhem-Johansson, V, Morlat, P, Mussini, C, Noguera-Julian, A, Stephan, C, Touloumi, G, Kirk, O, Mocroft, A, Reiss, P, Miro, J M, Carpenter, J R, Furrer, Hansjakob
Publikováno v:
Atkinson, Andrew; Zwahlen, Marcel; Barger, D; d'Arminio Monforte, A; De Wit, S; Ghosn, J; Girardi, E; Svedhem-Johansson, V; Morlat, P; Mussini, C; Noguera-Julian, A; Stephan, C; Touloumi, G; Kirk, O; Mocroft, A; Reiss, P; Miro, J M; Carpenter, J R; Furrer, Hansjakob (2021). Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE. Clinical infectious diseases, 73(2), pp. 195-202. The University of Chicago Press 10.1093/cid/ciaa615
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Background: Using data from the COHERE collaboration, we investigated whether primary prophylaxis for pneumocystis pneumonia (PcP) might be withheld in all patients on antiretroviral therapy (ART) with suppressed plasma human immunodeficiency virus (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4254b5445553c0ada42a26c96a523af3
https://boris.unibe.ch/144406/8/Atkinson_ClinInfectDis_2021.pdf
https://boris.unibe.ch/144406/8/Atkinson_ClinInfectDis_2021.pdf
Autor:
Atkinson, A., Miro, J. M., Mocroft, A., Reiss, P., Kirk, O., Morlat, P., Ghosn, J., Stephan, C., Mussini, C., Antoniadou, A., Doerholt, K., Girardi, E., De Wit, S., Kraus, D., Zwahlen, M., Furrer, H., Castagna, A., Fatkenheuer, G., Raben, D., Teira, R., Zangerle, R., Judd, A., Touloumi, G., Warszawski, J., Meyer, L., Dabis, F., Krause, M. M., Leport, C., Wittkop, L., Wit, F., Prins, M., Bucher, H., Gibb, D., Del Amo, J., Obel, N., Thorne, C., Perez-Hoyos, S., Hamouda, O., Bartmeyer, B., Chkhartishvili, N., Noguera-Julian, A., Antinori, A., d'Arminio Monforte, A., Brockmeyer, N., Prieto, L., Conejo, P. R., Soriano-Arandes, A., Battegay, M., Kouyos, R., Casabona, J., Goetghebuer, T., Sonnerborg, A., Torti, C., Sabin, C., Garrido, M., Haerry, D., Costagliola, D., d'Arminio-Monforte, A., del Amo, J., Chene, G., Barger, D., Schwimmer, C., Termote, M., Frederiksen, C. M., Brandt, R. S., Berenguer, J., Bohlius, J., Bouteloup, V., Cozzi-Lepri, A., Davies, M. -A., Dorrucci, M., Dunn, D., Egger, M., Guiguet, M., Grabar, S., Lambotte, O., Leroy, V., Lodi, S., Matheron, S., Monge, S., Nakagawa, F., Paredes, R., Phillips, A., Puoti, M., Rohner, E., Schomaker, M., Smit, C., Sterne, J., Thiebaut, R., Wqetu, C., van der Valk, M.
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of the International AIDS Society, 24(6):e25726. International AIDS Society
Atkinson, A, Miro, J M, Mocroft, A, Reiss, P, Kirk, O, Morlat, P, Ghosn, J, Stephan, C, Mussini, C, Antoniadou, A, Doerholt, K, Girardi, E, De Wit, S, Kraus, D, Zwahlen, M, Furrer, H, De Wit, S, Antoniadou, A, Castagna, A, Doerholt, K, Fätkenheuer, G, Raben, D, Teira, R, Zangerle, R, Judd, A, Zangerle, R, Touloumi, G, Warszawski, J, Meyer, L, Dabis, F, Krause, M M, Leport, C, Wittkop, L, Wit, F, Prins, M, Bucher, H, Gibb, D, Fätkenheuer, G, Del Amo, J, Obel, N, Thorne, C, Pérez-Hoyos, S, Hamouda, O, Bartmeyer, B, Chkhartishvili, N, Noguera-Julian, A, Antinori, A, d’Arminio Monforte, A & the Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD 2021, ' No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL ', Journal of the International AIDS Society, vol. 24, no. 6, e25726 . https://doi.org/10.1002/jia2.25726
Atkinson, Andrew; Miro, Jose M; Mocroft, Amanda; Reiss, Peter; Kirk, Ole; Morlat, Philippe; Ghosn, Jade; Stephan, Christoph; Mussini, Cristina; Antoniadou, Anastasia; Doerholt, Katja; Girardi, Enrico; De Wit, Stéphane; Kraus, David; Zwahlen, Marcel; Furrer, Hansjakob (2021). No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL. Journal of the International AIDS Society, 24(6), e25726. BioMed Central 10.1002/jia2.25726
Journal of the International AIDS Society
Universidad de Barcelona
Journal of the International AIDS Society, 24(6):e25726. International AIDS Society
Atkinson, A, Miro, J M, Mocroft, A, Reiss, P, Kirk, O, Morlat, P, Ghosn, J, Stephan, C, Mussini, C, Antoniadou, A, Doerholt, K, Girardi, E, De Wit, S, Kraus, D, Zwahlen, M, Furrer, H, De Wit, S, Antoniadou, A, Castagna, A, Doerholt, K, Fätkenheuer, G, Raben, D, Teira, R, Zangerle, R, Judd, A, Zangerle, R, Touloumi, G, Warszawski, J, Meyer, L, Dabis, F, Krause, M M, Leport, C, Wittkop, L, Wit, F, Prins, M, Bucher, H, Gibb, D, Fätkenheuer, G, Del Amo, J, Obel, N, Thorne, C, Pérez-Hoyos, S, Hamouda, O, Bartmeyer, B, Chkhartishvili, N, Noguera-Julian, A, Antinori, A, d’Arminio Monforte, A & the Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD 2021, ' No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL ', Journal of the International AIDS Society, vol. 24, no. 6, e25726 . https://doi.org/10.1002/jia2.25726
Atkinson, Andrew; Miro, Jose M; Mocroft, Amanda; Reiss, Peter; Kirk, Ole; Morlat, Philippe; Ghosn, Jade; Stephan, Christoph; Mussini, Cristina; Antoniadou, Anastasia; Doerholt, Katja; Girardi, Enrico; De Wit, Stéphane; Kraus, David; Zwahlen, Marcel; Furrer, Hansjakob (2021). No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL. Journal of the International AIDS Society, 24(6), e25726. BioMed Central 10.1002/jia2.25726
Journal of the International AIDS Society
Introduction: Since the beginning of the HIV epidemic in resource-rich countries, Pneumocystis jirovecii pneumonia (PjP) is one of the most frequent opportunistic AIDS-defining infections. The Collaboration of Observational HIV Epidemiological Resear
Autor:
Willemse, S., Smit, C., Sogni, P., Sarcletti, M., Uberti-Foppa, C., Wittkop, L., Raben, D., D'Arminio Monforte, A., Dabis, F., Van Der Valk, M., Judd, A., Zangerle, R., Touloumi, G., Warszawski, J., Meyer, L., Murielle, M., Ghosn, J., Leport, C., Reiss, P., Wit, F., Prins, M., Bucher, H., Gibb, D., Fatkenheuer, G., Obel, N., Thorne, C., Mocroft, A., Kirk, O., Stephan, C., Perez-Hoyos, S., Hamouda, O., Clinsurv, G., Bartmeyer, B., Chkhartishvili, N., Noguera-Julian, A., Antinori, A., Brockmeyer, N., Prieto, L., Pablo, R., Soriano-Arandes, A., Battegay, M., Kouyos, R., Mussini, C., Tookey, P., Casabona, J., Miro, J. M., Castagna, A., Konopnick, D., Goetghebuer, T., Sonnerborg, A., Torti, C., Sabin, C., Teira, R., Garrido, M., Haerry, D., Stephane, D., Jose, M., Costagliola, D., Raffaele, S., Julia, D., Chene, G., Barger, D., Schwimmer, C., Termote, M., Campbell, M., Frederiksen, C. M., Friis-Moller, N., Kjaer, J., Bohlius, J., Bouteloup, V., Cozzi-Lepri, A., Davies, M. -A., Dorrucci, M., Dunn, D., Egger, M., Furrer, H., Guiguet, M., Grabar, S., Lambotte, O., Leroy, V., Lodi, S., Matheron, S., Monge, S., Nakagawa, F., Paredes, R., Phillips, A., Puoti, M., Rohner, E., Schomaker, M., Sterne, J., Thiebaut, R.
Publikováno v:
Journal of viral hepatitis, 26(10), 1224-1228. Wiley-Blackwell
Journal of Viral Hepatitis
Journal of Viral Hepatitis
The incidence of hepatocellular carcinoma (HCC) in patients co-infected with HIV and hepatitis B virus (HBV) or hepatitis C virus (HCV) is increasing. In patients with cirrhosis, guidelines recommend HCC screening every 6 months. We assessed complian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e8b699fe5eccc8bc48badb7e45d2ebc
Autor:
Atkinson A., Zwahlen M., Barger D., D'arminio Monforte A., De Wit S., Ghosn J., Girardi E., Svedhem V., Morlat P., Mussini C., Noguera-Julian A., Stephan C., Touloumi G., Kirk O., Mocroft A., Reiss P., Miro J. M., Carpenter J. R., Furrer H., Judd A., Zangerle R., Warszawski J., Meyer L., Dabis F., Krause M. M., Leport C., Wittkop L., Wit F., Prins M., Bucher H., Gibb D., Fatkenheuer G., Del Amo J., Obel N., Thorne C., Perez-Hoyos S., Hamouda O., Bartmeyer B., Chkhartishvili N., Antinori A., Brockmeyer N., Prieto L., Rojo Conejo P., Soriano-Arandes A., Battegay M., Kouyos R., Casabona J., M. Miro J., Castagna A., Konopnick D., Goetghebuer T., Sonnerborg A., Torti C., Sabin C., Teira R., Garrido M., Haerry D., Costagliola D., D'arminio-Monforte A., Raben D., Chene G.
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical infectious diseases :an official publication of the Infectious Diseases Society of America, 73 (2
the Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 2021, ' Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus : An Emulation of a Pragmatic Trial in COHERE ', Clinical Infectious Diseases, vol. 73, no. 2, pp. 195-202 . https://doi.org/10.1093/cid/ciaa615
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2021, 73 (2), pp.195-202. ⟨10.1093/cid/ciaa615⟩
Clinical infectious diseases, 73(2), 195-202. Oxford University Press
Clinical infectious diseases :an official publication of the Infectious Diseases Society of America, 73 (2
the Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 2021, ' Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus : An Emulation of a Pragmatic Trial in COHERE ', Clinical Infectious Diseases, vol. 73, no. 2, pp. 195-202 . https://doi.org/10.1093/cid/ciaa615
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2021, 73 (2), pp.195-202. ⟨10.1093/cid/ciaa615⟩
Clinical infectious diseases, 73(2), 195-202. Oxford University Press
BACKGROUND: Using data from the COHERE collaboration, we investigated whether primary prophylaxis for pneumocystis pneumonia (PcP) might be withheld in all patients on antiretroviral therapy (ART) with suppressed plasma human immunodeficiency virus (
Autor:
Barger, D. M., Gebhard, J. W.
Publikováno v:
The American Journal of Psychology, 1952 Jul 01. 65(3), 450-457.
Externí odkaz:
https://www.jstor.org/stable/1418766